- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.09. | Takeda R&D President Andy Plump to Retire in 2027 | ||
| 14.09. | ShennonBio Names Cyril Konto CEO After $12M Raise | ||
| 14.09. | Eli Lilly Completes AtaiBeckley Acquisition | ||
| 11.09. | Servier Becomes Latest Company to License Owkin's K Pro AI Scientist | ||
| 11.09. | Samsung Biologics Signs $262M Manufacturing Deal With European Pharma Company | ||
| 11.09. | Exegenesis Bio, Modalis Partner on DMD Gene Therapy | ||
| 10.09. | Lonza to Add Commercial Spray-Drying Facility in Oregon | ||
| 10.09. | Retension Pharma Welcomes Two to Its Executive Team | ||
| 10.09. | VVMF Sydney Facility Gets Therapeutic Goods Manufacturing License | ||
| 10.09. | Glenmark, South Piedmont Launch Pharma Training Facility | ||
| 10.09. | Ritedose Names Carolyn Berg VP of Strategic Growth | ||
| 10.09. | CordenPharma Expands Injectable Manufacturing in Italy | ||
| 09.09. | 1cBio, Lee's Pharm Ink License Agreement for PARP1 Inhibitor in China, Southeast Asia | ||
| 09.09. | Systech Launches Intelligent Enterprise Traceability Platform | ||
| 09.09. | Matica Bio, Bondwell Partner on Texas Biotech | ||
| 09.09. | Schreiner MediPharm Labels Cut Oxygen Ingress in COC Syringes | ||
| 09.09. | Transcenta, WuXi Biologics Sign HiCB Licensing Deal | ||
| 08.09. | HeartBeat.bio, Cubase Bio Partner on Spatial Profiling for Cardiovascular Drug Discovery | ||
| 08.09. | Neurizon to Welcome Chris Bremer as CEO | ||
| 08.09. | Gilead Opens 182,000-Square-Foot Research Center in Foster City | ||
| 08.09. | Prilenia Taps Rick Munschauer as New Chief Medical Officer | ||
| 08.09. | Northway Biotech Opens €61M Cell Therapy CDMO Facility in Vilnius | ||
| 08.09. | Transgene, ProBioGen Broaden Viral Vector Partnership | ||
| 08.09. | Charles River Launches Automated Endosafe Manufacturing Suite | ||
| 08.09. | Hovione Names Stefan Doboczky as CEO |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.